Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells’ osteogenic differentiation
I-Chun Tai,1–3 Yao-Hsien Wang,3 Chung-Hwan Chen,3,4 Shu-Chun Chuang,3 Je-Ken Chang,3–5 Mei-Ling Ho1–3,6 1Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; 2Department of Physiology, College of Medicine, Kaohsiung Medical Universi...
Guardado en:
Autores principales: | Tai IC, Wang YH, Chen CH, Chuang SC, Chang JK, Ho ML |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/194e65feee534d999a20bace0e255638 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair
por: Tai IC, et al.
Publicado: (2013) -
The role of the ERK1/2 pathway in simvastatin-loaded nanomicelles and simvastatin in regulating the osteogenic effect in MG63 cells
por: Niu M, et al.
Publicado: (2018) -
In vitro proliferation and osteogenic differentiation of mesenchymal stem cells on nanoporous alumina
por: Song Y, et al.
Publicado: (2013) -
A Rho-actin signaling pathway shapes cell wall boundaries in Arabidopsis xylem vessels
por: Yuki Sugiyama, et al.
Publicado: (2019) -
Author Correction: Simvastatin reduces the carcinogenic effect of 3-methylcholanthrene in renal epithelial cells through histone deacetylase 1 inhibition and RhoA reactivation
por: Chih-Cheng Chang, et al.
Publicado: (2020)